StockData
LENSAR, Inc. logo

LENSAR, Inc. (LNSR) stock

LNSRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3022% below fair value
$4.91−0.38 (-7.18%)

Close on Nov 17, 2026Market cap $60.32MP/E –Yield –

Lensar operating margin

Operating margin is operating income as a percentage of revenue.

Lensar's operating margin for the twelve months ending Jun 30, 2026 was -13.5%. For fiscal 2025 it was -42.1%, against -19.9% the year before. The highest annual figure on record is -19.9% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-42.1%−22.1
FY2024Dec 31, 2024-19.9%+9.1
FY2023Dec 31, 2023-29.0%+28.1
FY2022Dec 31, 2022-57.1%−0.0
FY2021Dec 31, 2021-57.0%+13.1
FY2020Dec 31, 2020-70.1%−28.5
FY2019Dec 31, 2019-41.6%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202612.9%+58.1
Q1 FY2026Mar 31, 202616.7%+57.6
Q4 FY2025Dec 31, 2025-30.7%−23.0
Q3 FY2025Sep 30, 2025-52.9%−43.8
Q2 FY2025Jun 30, 2025-45.1%−3.3
Q1 FY2025Mar 31, 2025-40.9%−14.0
Q4 FY2024Dec 31, 2024-7.7%+16.8
Q3 FY2024Sep 30, 2024-9.2%+11.6
Q2 FY2024Jun 30, 2024-41.8%−17.9
Q1 FY2024Mar 31, 2024-26.9%+25.9
Q4 FY2023Dec 31, 2023-24.5%+1.1
Q3 FY2023Sep 30, 2023-20.8%+31.9
Q2 FY2023Jun 30, 2023-23.9%+60.7
Q1 FY2023Mar 31, 2023-52.8%+18.7
Q4 FY2022Dec 31, 2022-25.5%+9.3
Q3 FY2022Sep 30, 2022-52.7%+21.8
Q2 FY2022Jun 30, 2022-84.6%−29.3
Q1 FY2022Mar 31, 2022-71.6%+2.3
Q4 FY2021Dec 31, 2021-34.9%+47.8
Q3 FY2021Sep 30, 2021-74.5%−8.6
Q2 FY2021Jun 30, 2021-55.2%+20.9
Q1 FY2021Mar 31, 2021-73.8%−21.4
Q4 FY2020Dec 31, 2020-82.7%−59.8
Q3 FY2020Sep 30, 2020-65.9%+0.2
Q2 FY2020Jun 30, 2020-76.1%–
Q1 FY2020Mar 31, 2020-52.5%–
Q4 FY2019Dec 31, 2019-22.8%–
Q3 FY2019Sep 30, 2019-66.2%–

More Lensar figures

See a number that looks wrong?